Skip to main content
Log in

Heterogeneity of biotransformation of fluoranthene in perifused liver cells

  • Original Papers
  • Experimental Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

Pathways of biotransformation of the carcinogenic polycyclic hydrocarbon fluoranthene in individual isolated perifused liver cells were delineated using noninvasive microfluorescence spectroscopic techniques. An example of heterogeneity of coupling between phase I and phase II enzymes detected in a population of β-naphthoflavone-induced rat liver cells demonstrates the usefulness of the experimental model of perifused liver cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Babson JR, Russo-Rodriguez SE, Wattley RV, Bergstein PL, Rastetter WH, Liber HL, Andon BM, Thilly WG, Wogan GN (1986) Microsomal activation of fluoranthene to mutagenic metabolites. Toxicol Appl Pharmacol 85:355–366

    Article  PubMed  Google Scholar 

  • Busby WF, Goldman WE, Newborne PM, Wogan GN (1984) Tumorigenicity of fluoranthene in a new born mouse bioassay. Carcinogenesis 5:1311–1316

    PubMed  Google Scholar 

  • Conway JG, Kauffman FC, Tsukada T, Thurman RG (1984) Glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule. Mol Pharmacol 25:487–493

    PubMed  Google Scholar 

  • El Mouelhi M, Kauffman FC (1986) Sublobular distribution of transferase and hydrolases associated with glucuronide, sulfate and glutathione conjugation in human liver. Hepatology 6:450–456

    PubMed  Google Scholar 

  • Foster JR, Elcombe CR, Boobis AR, Davies DS, Sesardic D, McQuade J, Robson RT, Hayward C, Lock EA (1986) Immunocytochemical localization of cytochrome P-450 in hepatic and extra-hepatic tissues of the rat with a monoclonal antibody againts cytochrome P-450. Biochem Pharmacol 35:4543–4554

    Article  PubMed  Google Scholar 

  • Gooding PE, Chayen J, Sawyer B, Slater TF (1978) Cytochrome P-450 distribution in rat liver and the effect of sodium phenobarbitone administration. Chem Biol Interact 20:299–310

    Article  PubMed  Google Scholar 

  • Höhne M (1983) Biotransformation des Fluoranthen durch das Cytochrom P-450-System und Charaketerisierung von rekonstituierten Cytochrom P-450-Systemen. Dissertation, Freie Universität Berlin

  • Ivanetich KM, Ziman MR, Bradshaw JJ (1982) 1,1,1-Trichloropropene-2,3-oxide: an alternate mechanism for its inhibition of cytochrome P-450. Res Commun Chem Pathol Pharmacol 35:111–120

    PubMed  Google Scholar 

  • Jungermann K, Katz N (1982) Metabolic heterogeneity of liver parenchyma. In: Sies H (ed) Metabolic compartmentation. Academic Press, London New York Paris, pp 411–435

    Google Scholar 

  • LaVoie EJ, Hecht SS, Bedenko V, Hoffmann D (1982) Identification of the mutagenic metabolites of fluoranthene, 2-methylfluoranthene and 3-methylfluoranthene. Carcinogenesis 3:841–846

    PubMed  Google Scholar 

  • Omura T, Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. J Biol Chem 239:2379–2385

    PubMed  Google Scholar 

  • Rastetter WH, Nachbar RB, Russo-Rodriguez S, Wattley RV (1982) Fluoranthene: synthesis and mutagenicity of four diol epoxides. J Org Chem 47:4873–4878

    Google Scholar 

  • Rice JE, LaVoie EJ, Hoffmann D (1982) synthesis of the isomeric phenols and the trans-2,3-dihydrodiol of fluoranthene. J Org Chem 48:2360–2363

    Google Scholar 

  • Schlenker A (1982) Untersuchung der Biotransformation von Fluoranthen in Mikrosomen, Leberzellsuspensionen und einzelnen Leberzellen. Dissertation, Technische Universität Braunschweig

  • Seglen PO (1973) Preparation of rat liver cells. Exp Cell Res 76:25–30

    PubMed  Google Scholar 

  • Shenbor MI, Cheban GA (1969) Preparation of fluoranthenol-3 by the action of lead tetraacetate on fluoranthene. J Org Chem USSR 5:143

    Google Scholar 

  • Shimada T, Sato R (1979) Inhibition of mono-oxygenase activities by 1,1,1-trichloropropene 2,3-oxide, an inhibitor of epoxide hydrase, in rat liver microsomes. Biochem Pharmacol 28:1777–1781

    Article  PubMed  Google Scholar 

  • Stier Am, Nolte KH, Schlenker A, Schumann W, Zuretti FM (1980) Toxicological studies of liver cells by microspectrofluorometry. Arch Toxicol 44:45–54

    Article  PubMed  Google Scholar 

  • Stier A, Finch SAE, Greinert R, Taniguchi H (1985) Membrane protein interactions in biotransformation. In: Vereczkey L, Magyar K (eds) Cytochrome P-450, biochemistry, biophysics and induction. Akademiai Kiado, Budapest, pp 139–146

    Google Scholar 

  • Strobel HW, Lau PP (1982) Five forms of cytochromes P-450 from β-naphthoflavone pretreated rats. In: Sato R, Kato R (eds) Microsomes, drug oxidations, and drug toxicity. Wiley, New York, pp 91–92

    Google Scholar 

  • Ullrich D, Fischer G, Katz N, Bock KW (1984) Intralobular distribution of UDP-glucuronosyltransferase in livers from untreated, 3-methylcholanthrene- and phenobarbital-treated rats. Chem Biol Interact 48:181–190

    Article  PubMed  Google Scholar 

  • Wolf CR, Buchmann A, Friedberg T, Moll E, Kuhlmann WD, Kunz HW, Oesch F (1984) Dynamics of the localization of drug metabolizing enzymes in tissues and cells. Biochem Soc Trans 12:60–62

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Dedicated to Werner Kunz on the occasion of his 65th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stier, A., Schlenker, A., Sidhu, J. et al. Heterogeneity of biotransformation of fluoranthene in perifused liver cells. J Cancer Res Clin Oncol 114, 39–46 (1988). https://doi.org/10.1007/BF00390484

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00390484

Key words

Navigation